Thalamus size and outcome in schizophrenia

Schizophrenia Research

Volumn 71, Issue 2-3, 2004, Pages 473-484

  Brickman, Adam M ^a,b,c   Buchsbaum, Monte S ^a   Shihabuddin, Lina ^a,d   Byne, William ^a,d   Newmark, Randall E ^a   Brand, Jesse ^a   Ahmed, Shabeer ^a   Mitelman, Serge A ^a   Hazlett, Erin A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c BROWN UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Functional outcome; MRI; Schizophrenia; Thalamus

Indexed keywords

ADULT; ARTICLE; AUTOPSY; BRAIN SIZE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; PULVINAR; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TEMPORAL LOBE; THALAMUS;

ADULT; FEMALE; FRONTAL LOBE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SCHIZOPHRENIA; TEMPORAL LOBE; THALAMUS;

EID: 4944241494     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.03.011     Document Type: Article

References (51)

1. Ananth H., Popescu I., Critchley H.D., Good C.D., Frackowiak R.S., Dolan R.J. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am. J. Psychiatry. 159(9):2002;1497-1505
2. Andreasen N., Flaum M., Arndt S. The comprehensive assessment of symptoms and history (CASH): an instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry. 49:1992;615-623
3. Andreasen N.C., Arndt S., Swayze V. II, Cizadlo T., Flaum M., O'Leary D., Ehrhardt J.C., Yuh W.T. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 266:1994;221
4. Arciniegas D., Rojas D.C., Teale P., Sheeder J., Sandberg E., Reite M. The thalamus and the schizophrenia phenotype: failure to replicate reduced volume. Biol. Psychiatry. 45(10):1999;1329-1335
5. Bachevalier J., Meunier M., Lu M.X., Ungerleider L.G. Thalamic and temporal cortex input to medial prefrontal cortex in rhesus monkeys. Exp. Brain Res. 115(3):1997;430-444
6. Brickman A.M., Buchsbaum M.S., Shihabuddin L., Hazlett E.A., Borod J.C., Mohs R.C. Striatal size, glucose metabolic rate, and verbal learning in normal aging. Brain Res. Cogn. Brain Res. 17(1):2003;106-116
7. Bridle N., Pantelis C., Wood S.J., Coppola R., Velakoulis D., McStephen M., Tierney P., Le T.L., Torrey E.F., Weinberger D. Thalamic and caudate volumes in monozygotic twins discordant for schizophrenia. Aust. N. Z. J. Psychiatry. 36(3):2002;347-354
8. Buchsbaum M.S., Ingvar D.H., Kessler R., Waters R.N., Cappelletti J., van Kammen D.P., King A.C., Johnson J.L., Manning R.G., Flynn R.W., Mann L.S., Bunney W.E. Jr., Sokoloff L. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch. Gen. Psychiatry. 39:1982;251-259
9. Buchsbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., Haier R.J., Wu J., Bunney W.E. PET and MRI of the Thalamus in Never-Medicated Patients with Schizophrenia. Am. J. Psychiatry. 153:1996;191-199
10. Buchsbaum M.S., Shihabuddin L., Hazlett E.A., Schroder J., Haznedar M.M., Powchick P., Spiegel-Cohen J., Wei T., Singer M.B., Davis K.L. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate. Schizophr. Res. 55(1-2):2002;25-40
11. Buchsbaum M.S., Shihabuddin L., Brickman A.M., Miozzo R., Prikryl R., Shaw R., Davis K. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr. Res. 64(1):2003;53-62
12. Byne W., Buchsbaum M.S., Kemether E., Hazlett E.A., Shinwari A., Mitropoulou V., Siever L.J. Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch. Gen. Psychiatry. 58(2):2001;133-140
13. Byne W., Buchsbaum M.S., Mattiace L.A., Hazlett E.A., Kemether E., Elhakem S.L., Purohit D.P., Haroutunian V., Jones L. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am. J. Psychiatry. 159(1):2002;59-65
14. Cahn W., Pol H.E., Lems E.B., van Haren N.E., Schnack H.G., van der Linden J.A., Schothorst P.F., van Engeland H., Kahn R.S. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch. Gen. Psychiatry. 59(11):2002;1002-1010
15. Crow T.J. Schizophrenia as the price that homo sapiens pay for language: A resolution of the central paradox in the origin of the species. Brain Res. Brain Res. Rev. 31(2-3):2000;118-129
16. Cullen T.J., Walker M.A., Parkinson N., Craven R., Crow T.J., Esiri M.M., Harrison P.J. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophr. Res. 60(2-3):2003;157-166
17. Danos P., Baumann B., Bernstein H.G., Stauch R., Krell D., Falkai P., Bogerts B. The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study. Psychiatry Res. 114(1):2002;1-9
18. Danos P., Baumann B., Kramer A., Bernstein H.G., Stauch R., Krell D., Falkai P., Bogerts B. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr. Res. 60(2-3):2003;141-155
19. Davis K.L., Buchsbaum M.S., Shihabuddin L., Spiegel-Cohen J., Metzger M., Frecska E., Keefe R.S., Powchick P. Ventricular enlargement in poor-outcome schizophrenia. Biol. Psychiatry. 43:1998;783-793
20. Deicken R.F., Eliaz Y., Chosiad L., Feiwell R., Rogers L. Magnetic resonance imaging of the thalamus in male patients with schizophrenia. Schizophr. Res. 58(2-3):2002;135-144
21. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23(3):1997;437-458
22. Gur R.E., Cowell P., Turetsky B.I., Gallacher F., Cannon T., Bilker W., Gur R.C. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch. Gen. Psychiatry. 55(2):1998;145-152
23. Harvey P.D., Putman K.M., Davidson M., Kahn R.S., Powchik P., McQueeney R., Keefe R.S., Davis K.L. Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients. Psychiatry Res. 38:1991;285-292
24. Hazlett E.A., Buchsbaum M.S., Haznedar M.M., Singer M.B., Schnurr D.B., Jimenez E.A., Buchsbaum B.R., Troyer B.T. Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology. 35:1998;186-198
25. Hazlett E.A., Buchsbaum M.S., Byne W., Wei C.T., Spiegel-Cohen J., Geneve C., Kinderlehrer R., Haznedar M., Shihabuddin L., Siever L.J. Three-dimensional analysis with MRI and PET of the shape, size, and function of the thalamus in the schizophrenia spectrum. Am. J. Psychiatry. 156:1999;1190-1199
26. Highley J.R., Walker M.A., Crow T.J., Esiri M.M., Harrison P.J. Low medial and lateral right pulvinar volumes in schizophrenia: a postmortem study. Am. J. Psychiatry. 160(6):2003;1177-1179
27. Ho B.C., Andreasen N.C., Nopoulos P., Arndt S., Magnotta V., Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry. 60(6):2003;585-594
28. Hulshoff Pol H.E., Schnack H.G., Mandl R.C., van Haren N.E., Koning H., Collins D.L., Evans A.C., Kahn R.S. Focal gray matter density changes in schizophrenia. Arch. Gen. Psychiatry. 58(12):2001;1118-1125
29. Ingvar D.H. Regional cerebral blood flow in organic dementia and in chronic schizophrenia. Triangle. 13(1):1974;17-23
30. Innocenti G.M., Ansermet F., Parnas J. Schizophrenia, neurodevelopment, and corpus callosum. Mol. Psychiatry. 8(3):2003;261-274
31. Jones E. Cortical development and thalamic pathology in schizophrenia. Schizophr. Bull. 23:1997;483-501
32. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13(2):1987;261-276
33. Keefe R.S., Mohs R.C., Losonczy M.F., Davidson M., Silverman J.M., Kendler K.S., Horvath T.B., Nora R., Davis K.L. Characteristics of very poor outcome schizophrenia. Am. J. Psychiatry. 144(7):1987;889-895
34. Keefe R.S., Mohs R.C., Davidson M., Losonczy M.F., Silverman J.M., Lesser J.C., Horvath T.B., Davis K.L. Kraepelinian schizophrenia: a subgroup of schizophrenia? Psychopharmacol. Bull. 24:1988;56-61
35. Keefe R.S., Frescka E., Apter S.H., Davidson M., Macaluso J.M., Hirschowitz J., Davis K.L. Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. Am. J. Psychiatry. 153:1996;806-811
36. Kemether E., Buchsbaum M.S., Byne W., Hazlett E.A., Haznedar M., Brickman A.M., Platholi J., Bloom R. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch. Gen. Psychiatry. 60(10):2003;983-991
37. Konick L.C., Friedman L. Meta-analysis of thalamic size in schizophrenia. Biol. Psychiatry. 49(1):2001;28-38
38. Mitelman S.A., Shihabuddin L., Brickman A.M., Hazett E.A., Buchsbaum M.S. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in good and poor outcome schizophrenia. Am. J. Psychiatry. 160(12):2003;2154-2168
39. Portas C.M., Goldstein J.M., Shenton M.E., Hokama H.H., Wible C.G., Fischer I., Kikinis R., Donnino R., Jolesz F.A., McCarley R.W. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol. Psychiatry. 43(9):1998;649-659
40. Rossi A., Bustini M., Prosperini P., Marinangeli M.G., Splendiani A., Daneluzzo E., Stratta P. Neuromorphological abnormalities in schizophrenic patients with good and poor outcome. Acta Psychiatr. Scand. 101(2):2000;161-166
41. Roy M., Lehoux C., Emond C., Laplante L., Bouchard R., Everett J., Merette C., Maziade M. A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia. Schizophr. Res. 62:2003;155-163
42. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., Haznedar M.M., Harvey P.D., Newman A., Schnur D.B., Spiegel-Cohen J., Wei T., Machac J., Knesaurek K., Vallabhajosula S., Biren M.A., Ciaravolo T.M., Luu-Hsia C. Dorsal striatal size, shape, and metabolic rate in never-medicated schizophrenics performing a verbal learning task. Arch. Gen. Psychiatry. 55(3):1998;235-243
43. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., Silverman J., New A., Brickman A.M., Mitropoulou V., Nunn M., Fleischman M.B., Tang C., Siever L.J. Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch. Gen. Psychiatry. 58(9):2001;877-884
44. Staal W.G., Hulshoff Pol H.E., Schnack H.G., van Haren N.E., Seifert N., Kahn R.S. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. Am. J. Psychiatry. 158(7):2001;1140-1142
45. Stein D.J., Buchsbaum M.S., Hof P.R., Siegel B.V. Jr., Shihabuddin L. Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease. Neuropsychobiology. 37:1998;10-19
46. Strungas S., Christensen J.D., Holcomb J.M., Garver D.L. State-related thalamic changes during antipsychotic treatment in schizophrenia: Preliminary observations. Psychiatry Res. 124(2):2003;121-124
47. Sullivan E.V., Rosenbloom M.J., Serventi K.L., Deshmukh A., Pfefferbaum A. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia. Am. J. Psychiatry. 160(6):2003;1110-1116
48. Wall J.T., Symonds L.L., Kaas J.H. Cortical and subcortical projections of the middle temporal area (MT) and adjacent cortex in galagos. J. Comp. Neurol. 211(2):1982;193-214
49. Yeterian E.H., Pandya D.N. Thalamic connections of the cortex of the superior temporal sulcus in the rhesus monkey. J. Comp. Neurol. 282(1):1989;80-97
50. Yeterian E.H., Pandya D.N. Corticothalamic connections of the superior temporal sulcus in rhesus monkeys. Exp. Brain Res. 83(2):1991;268-284
51. Young K.A., Manaye K.F., Liang C., Hicks P.B., German D.C. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry. 47(11):2000;944-953